T2 Biosystems Inc - ESG Rating & Company Profile powered by AI
This analysis of T2 Biosystems Inc employs intelligence from across the internet and also from available filings by T2 Biosystems Inc. Browse to the bottom of this page for potential risks for T2 Biosystems Inc based on industry, geography and size. This page is a free Environmental, Social and Governance assessment for T2 Biosystems Inc.
T2 Biosystems Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 8.0, social score of 4.8 and governance score of 4.0.
5.6
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
579 | Tonix Pharmaceuticals Holding Corp | 5.7 | High |
579 | VIVA Biotech Holdings | 5.7 | High |
602 | T2 Biosystems Inc | 5.6 | High |
602 | Celltrion Inc | 5.6 | High |
602 | Adaptimmune Therapeutics PLC | 5.6 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does T2 Biosystems Inc have an accelerator or VC vehicle to help deliver innovation?
Does T2 Biosystems Inc disclose current and historical energy intensity?
Does T2 Biosystems Inc report the average age of the workforce?
Does T2 Biosystems Inc reference operational or capital allocation in relation to climate change?
Does T2 Biosystems Inc disclose its ethnicity pay gap?
Does T2 Biosystems Inc disclose cybersecurity risks?
Does T2 Biosystems Inc offer flexible work?
Does T2 Biosystems Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does T2 Biosystems Inc disclose the number of employees in R&D functions?
Does T2 Biosystems Inc conduct supply chain audits?
Does T2 Biosystems Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does T2 Biosystems Inc conduct 360 degree staff reviews?
Does T2 Biosystems Inc disclose the individual responsible for D&I?
Does T2 Biosystems Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does T2 Biosystems Inc disclose current and / or historical scope 2 emissions?
Does T2 Biosystems Inc disclose water use targets?
Does T2 Biosystems Inc have careers partnerships with academic institutions?
Did T2 Biosystems Inc have a product recall in the last two years?
Does T2 Biosystems Inc disclose incidents of discrimination?
Does T2 Biosystems Inc allow for Work Councils/Collective Agreements to be formed?
Has T2 Biosystems Inc issued a profit warning in the past 24 months?
Does T2 Biosystems Inc disclose parental leave metrics?
Does T2 Biosystems Inc disclose climate scenario or pathway analysis?
Does T2 Biosystems Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does T2 Biosystems Inc disclose the pay ratio of women to men?
Does T2 Biosystems Inc support suppliers with sustainability related research and development?
Does T2 Biosystems Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does T2 Biosystems Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is T2 Biosystems Inc involved in embryonic stem cell research?
Does T2 Biosystems Inc disclose GHG and Air Emissions intensity?
Does T2 Biosystems Inc disclose its waste policy?
Does T2 Biosystems Inc report according to TCFD requirements?
Does T2 Biosystems Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does T2 Biosystems Inc disclose energy use targets?
Does T2 Biosystems Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does T2 Biosystems Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for T2 Biosystems Inc
These potential risks are based on the size, segment and geographies of the company.
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance technology that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument for detecting pathogens associated with sepsis and Lyme disease, and other applications, as well as T2Candida Panel that identifies the species of Candida, a fungal pathogen known to cause sepsis directly from whole blood. In addition, it provides T2Bacteria Panel, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; T2SARS-CoV-2 Panel, a COVID-19 molecular diagnostic test; and T2Resistance Panel for the early and sensitive detection of carbapenemase-resistance markers. Further, it develops T2Cauris Panel, a multi-drug resistant pathogen; and T2Lyme Panel for the detection of various strains of Lyme disease-causing bacteria. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.